https://doi.org/10.4081/hmr.v2i3.365

Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3)

Vol. 2 No. 3: Cervo Preclinical Working Conference, Cervo Ligure, October 6-8, 2005
Published: June 8, 2009
Abstract Views: 152
PDF: 142
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Dr. Santini
support@pagepress.org
B Vincenzi
M Rosolowski
L Altucci
M Campioni
M Loeffler
A Baldi
G Tonini
The LNCaP and the PC3 cells are widely used as models for prostate cancer. Aminobisphosphonates have clearly demonstrated to inhibit proliferation and induce apoptosis in these cells by interfering with the mevalonate pathway. The types and pattern of downstream genes modulated by zoledronic acid (ZA) treatment are unknown. We used a cDNA microarray platform to analyse the genetic modulation induced by ZA in the PC3 prostate cancer cell line.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Santini, D., Vincenzi, B., Rosolowski, M., Altucci, L., Campioni, M., Loeffler, M., Baldi, A., & Tonini, G. (2009). Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3). Hematology Meeting Reports (formerly Haematologica Reports), 2(3). https://doi.org/10.4081/hmr.v2i3.365
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).